BRPI0313987A2 - fator-1 derivado de cédula estromática que media o retorno da cédula-tronco e a regeneração tecidual em cardiomiopatia isquêmica - Google Patents

fator-1 derivado de cédula estromática que media o retorno da cédula-tronco e a regeneração tecidual em cardiomiopatia isquêmica

Info

Publication number
BRPI0313987A2
BRPI0313987A2 BRPI0313987A BRPI0313987A BRPI0313987A2 BR PI0313987 A2 BRPI0313987 A2 BR PI0313987A2 BR PI0313987 A BRPI0313987 A BR PI0313987A BR PI0313987 A BRPI0313987 A BR PI0313987A BR PI0313987 A2 BRPI0313987 A2 BR PI0313987A2
Authority
BR
Brazil
Prior art keywords
ballot
stromal
tissue regeneration
derived factor
ischemic cardiomyopathy
Prior art date
Application number
BRPI0313987A
Other languages
English (en)
Inventor
T Askari Arman
S Penn Marc
Kiedrowski Matthew
Original Assignee
Cleveland Clinic Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cleveland Clinic Found filed Critical Cleveland Clinic Found
Publication of BRPI0313987A2 publication Critical patent/BRPI0313987A2/pt
Publication of BRPI0313987A8 publication Critical patent/BRPI0313987A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0375—Animal model for cardiovascular diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0313987A 2002-08-22 2003-08-21 fator-1 derivado de cédula estromática que media o retorno da cédula-tronco e a regeneração tecidual em cardiomiopatia isquêmica BRPI0313987A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40527402P 2002-08-22 2002-08-22
US10/426,712 US20040037811A1 (en) 2002-08-22 2003-04-30 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
PCT/US2003/026013 WO2004017978A1 (en) 2002-08-22 2003-08-21 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy

Publications (2)

Publication Number Publication Date
BRPI0313987A2 true BRPI0313987A2 (pt) 2017-10-10
BRPI0313987A8 BRPI0313987A8 (pt) 2018-04-24

Family

ID=31891492

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0313987A BRPI0313987A8 (pt) 2002-08-22 2003-08-21 fator-1 derivado de cédula estromática que media o retorno da cédula-tronco e a regeneração tecidual em cardiomiopatia isquêmica

Country Status (8)

Country Link
US (1) US20040037811A1 (pt)
EP (2) EP1542701B1 (pt)
JP (1) JP4280708B2 (pt)
AU (1) AU2003268131A1 (pt)
BR (1) BRPI0313987A8 (pt)
CA (1) CA2504019C (pt)
CO (1) CO5690564A2 (pt)
WO (1) WO2004017978A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8147824B2 (en) 1999-08-05 2012-04-03 Athersys, Inc. Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
US20070111935A1 (en) * 2000-04-06 2007-05-17 Franco Wayne P Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
US9694038B2 (en) 2000-04-06 2017-07-04 Wayne P. Franco Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
US10281478B2 (en) 2000-04-06 2019-05-07 Wayne P. Franco Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
US20050277576A1 (en) * 2000-04-06 2005-12-15 Franco Wayne P Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
US20050271639A1 (en) * 2002-08-22 2005-12-08 Penn Marc S Genetically engineered cells for therapeutic applications
US20040258669A1 (en) * 2002-11-05 2004-12-23 Dzau Victor J. Mesenchymal stem cells and methods of use thereof
JP5269411B2 (ja) * 2004-06-21 2013-08-21 ザ クリーブランド クリニック ファウンデーション 幹細胞をホーミングさせるためのｃｃｒリガンド
NZ565639A (en) * 2005-10-31 2012-03-30 Serono Lab Use of SDF-1 for the treatment and/or prevention of neurological diseases
US11000546B2 (en) 2005-11-09 2021-05-11 Athersys, Inc. Immunomodulatory properties of MAPCs and uses thereof
US10117900B2 (en) 2005-11-09 2018-11-06 Athersys, Inc. MAPC treatment of brain injuries and diseases
CN101410125A (zh) * 2006-01-23 2009-04-15 阿特西斯公司 脑损伤和疾病的mapc治疗
US7696309B2 (en) 2006-10-23 2010-04-13 The Brigham And Women's Hospital, Inc. Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
ES2520044T3 (es) * 2007-03-30 2014-11-11 The Cleveland Clinic Foundation SDF-1 para su uso en el tratamiento de trastornos vasculares periféricos isquémicos
CA2709398C (en) 2007-12-14 2017-11-07 The Cleveland Clinic Foundation Use of stromal cell-derived factor 1 for promoting wound healing
CA2772610C (en) * 2009-08-28 2018-01-23 The Cleveland Clinic Foundation Sdf-1 delivery for treating ischemic tissue
US9308277B2 (en) 2010-02-25 2016-04-12 Mesoblast International Sàrl Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
WO2011121036A2 (en) * 2010-03-30 2011-10-06 Vib Vzw Induction of arteriogenesis using specific factors or by cell therapy with polarized myeloid cells
US9677042B2 (en) 2010-10-08 2017-06-13 Terumo Bct, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
WO2012094512A2 (en) * 2011-01-05 2012-07-12 The Cleveland Clinic Foundation Myocardial tissue targeting peptides
WO2012170495A1 (en) 2011-06-07 2012-12-13 Provasculon, Inc. Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
US9617506B2 (en) 2013-11-16 2017-04-11 Terumo Bct, Inc. Expanding cells in a bioreactor
EP3613841B1 (en) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passive replacement of media
RU2557385C1 (ru) * 2014-06-18 2015-07-20 Общество с ограниченной ответственностью "НекстГен" Кодон-оптимизированные последовательности и фармацевтическая композиция для восстановления кровеносных сосудов
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US10959425B2 (en) 2016-04-29 2021-03-30 Hope Biosciences, Llc Method of banking stem cells
US10988731B2 (en) 2016-04-29 2021-04-27 Hope Biosciences, Llc Formulation for storage, transportation, and delivery of protein rich conditioned medium
US11111480B2 (en) 2016-04-29 2021-09-07 Hope Biosctences, Llc Culture media for multipotent stem cells
US10513689B2 (en) * 2016-04-29 2019-12-24 Hope Biosciences, Llc Culture media for multipotent stem cells
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3656842A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2096222C (en) 1990-11-13 1998-12-29 Stephen D. Lupton Bifunctional selectable fusion genes
AU6953394A (en) 1993-05-21 1994-12-20 Targeted Genetics Corporation Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
US5602301A (en) * 1993-11-16 1997-02-11 Indiana University Foundation Non-human mammal having a graft and methods of delivering protein to myocardial tissue
JP3961019B2 (ja) * 1995-02-28 2007-08-15 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 遺伝子転移媒介の血管形成療法
US5980887A (en) * 1996-11-08 1999-11-09 St. Elizabeth's Medical Center Of Boston Methods for enhancing angiogenesis with endothelial progenitor cells
WO1999040197A2 (en) * 1998-02-06 1999-08-12 Collateral Therapeutics, Inc. Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
WO1999045775A1 (en) * 1998-03-09 1999-09-16 St. Elizabeth's Medical Center Compositions and methods for modulating vascularization
US6358697B2 (en) * 1999-04-21 2002-03-19 Children's Hospital Medical Center Intracellular pharmaceutical targeting
AU2001284695A1 (en) * 2000-07-31 2002-02-13 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium

Also Published As

Publication number Publication date
EP2520302A1 (en) 2012-11-07
JP4280708B2 (ja) 2009-06-17
CA2504019A1 (en) 2004-03-04
EP1542701A1 (en) 2005-06-22
CA2504019C (en) 2015-06-02
EP1542701B1 (en) 2012-07-18
WO2004017978A1 (en) 2004-03-04
US20040037811A1 (en) 2004-02-26
CO5690564A2 (es) 2006-10-31
JP2006507244A (ja) 2006-03-02
EP2520302B1 (en) 2016-08-17
BRPI0313987A8 (pt) 2018-04-24
AU2003268131A1 (en) 2004-03-11
EP1542701A4 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
BRPI0313987A2 (pt) fator-1 derivado de cédula estromática que media o retorno da cédula-tronco e a regeneração tecidual em cardiomiopatia isquêmica
ATE251375T1 (de) Wandler, insbesondere zum einsatz in akustischen vorrichtungen
DE602005013644D1 (de) Speichermedium mit darauf gespeichertem Spielprogramm und Spielgerät dafür
NO20021460D0 (no) Ventil for bruk i brönner
DE60312873D1 (de) Elektrochirurgisches instrument zum verschluss von gefässen
NO20021218L (no) Fremgangsmåte for å bestemme innsynking i et reservoar
ITTO20050766A1 (it) Dispositivo di fissaggio a tenuta in particolare per creare una barriera all'umidita', alla polvere e al rumore
DE602005027373D1 (de) Verschlechterungsinformations-wiederherstellungsverfahren und -einrichtung
ITTO20050250A1 (it) Struttura insonorizzante in un'unita' motrice.
DE60311954D1 (de) Magnetischer Direktzugriffspeicher zur Speicherung von Informationen unter Verwendung des Magnetoresistivereffekts
ITTO20021035A1 (it) Dispositivo di memoria non volatile a lettura e scrittura simulante.
DE602004007428D1 (de) Spielgerät und Speichermedium mit darauf gespeichertem Spielprogramm
NO20031920D0 (no) Aktiveringsanordning, spesielt for anvendelse i en trotlingsanordning
DE602004017115D1 (de) Inhaltsadressierbare Speicheranordnung zum Auffinden von Daten inwelchen der Manhattan Abstand minimal ist
FI20045505A (fi) Laitteen muistiin tallennettavan tiedon suojaaminen
FI20030734A (fi) Paperinvalmistuksessa käyttökelpoinen komponentti ja sen käyttö
DE60100932D1 (de) Ein Speicherverwaltungsgerät, -methode,-programm und rechnerlesbares Speichermedium zum Speichern des Speicherverwaltungsprogrammes
NO20035022D0 (no) Forenklet stempel glidbart i en sylinder
DE60300387D1 (de) Steuergerät für eine Drosselklappe
FR2872244B1 (fr) Electrovanne a clapet d'arret d'evacuation
FI20021677A (fi) Järjestely paperi-/kartonkirainan päällystyslaitteessa
DE502004006704D1 (de) Lagerung zum Lagern von speziellen Gleiskonstruktionen
NO20030319D0 (no) Fremgangsmåte og system for å finne en samsvarende i en database angående bölgeformer
DE50312833D1 (de) Einrichtung zum stapeln flacher sendungen in eine stapelaufnahme
ATA5042000A (de) Einrichtung zum verwahren von gegenständen

Legal Events

Date Code Title Description
B12F Other appeals [chapter 12.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete